EXODIAB: Excellence of Diabetes Research in Sweden
1 – 10 of 4727
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
The impact of comorbidity burden on outcomes following endovascular thrombectomy for acute ischemic stroke : A nationwide prospective observational study
- Contribution to journal › Article
-
Mark
Identification of gut microbiome signatures and metabolites associated with albuminuria in type 2 diabetes
- Contribution to journal › Article
-
Mark
Adherence to the EAT-Lancet diet, plasma proteomics and the risk of chronic obstructive pulmonary disease
- Contribution to journal › Article
-
Mark
DAPAgliflozin for renal protection in heart transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
- Contribution to journal › Article
-
Mark
Type 1 Diabetes
(2026) p.12-23
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The prospective association between high-density lipoprotein (HDL) cholesterol and risk of incident fractures in the general population
- Contribution to journal › Article
-
Mark
HMGCR and rosuvastatin regulates GLP-1 secretion and expression - a translational study
- Contribution to journal › Article
-
Mark
Associations between biomarkers and p-wave indices in relation to atrial fibrillation development in heart failure patients
- Contribution to journal › Article
-
Mark
The rise and fall of a paradigm and conceiving a new hypothesis for type 1 diabetes
- Contribution to journal › Letter
-
Mark
SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? : Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications
- Contribution to journal › Article
